Skip to main content
. 2020 Jan 2;26:1. doi: 10.1186/s40885-019-0132-x

Table 1.

Comparison of dedicated heart failure registries

KorAHF [36] KorHF [37] ASIAN-HF [38] ATTEND [39] ADHERE [40, 41] ESC-HF-LT [42]
2011–2014 2004–2009 2012–2015 2007–2011 2002–2004 2011–2013
N 5625 3200 5276 4837 159,168 4449
Age, years (SD) 68.5 (14.5) 67.6 (14.3) 59.6 (13.1) 73.0 (13.8) 72.4 (14.1) 69.4 (13.0)
Male, % 53.2 55.9 78.2 57.9 48.4 62.6
BMI, kg/m2 23.3 (3.9) 23.2 (4.0) 24.9 (5.1) 28.7 (5.4)
NYHA class III-IV, % 84.8 74.0 35 81.4 76 85.2
SBP, mmHg 131.2 (30.3) 130.5 (3.2) 118.4 (20.2) 145.5 (36.7) 143.9 (33.2) 133.5 (28.2)
DBP, mmHg 78.6 (18.8) 77.9 (18.0) 72.4 (12.6) 82.6 (22.6) 77.7 (20.2)
HR, beats/minute 92.6 (26.0) 91.2 (25.4) 79.7 (16.2) 98.6 (29.1) 90.8 (25.3)
EF, % 37.7 ± 15.6 38.5 ± 15.7 28 [22, 33]

53.4% with

EF <40%

37.8 ± 17.3 39.0 [30, 43]
Etiology (%)
 - Hypertension 4.0 36.7 18

Up to 30%

in EF ≥ 55%

8.2
 - Ischemic heart disease 37.6 52.3 47.0 31.1 56.5
Medical history (%)
 - Hypertension 62.2 46.5 51.9 69.3 73.9 65.6
 - Ischemic heart disease 42.9 50.2 57.5 53.8
 - Diabetes mellitus 40.0 30.5 40.4 36.2 44 39.0
 - Atrial fibrillation / atrial flutter 28.5 20.8 17.9 39.6 30.9 44.0
 - Renal insufficiency 14.3 9.2 30.1 25.3
 - Stroke / transient ischemic attack 15.2 18.9 6.4 14.0 12.5
 - Chronic lung disease 11.3 3.5 8.3 9.5 31.4 20.1
 - Previous heart failure 47.8 29.6 64.1 36.1 75.6 70.9
Medications at discharge
 - ACE inhibitor 29.5 17.9 51.0 70–75 83.1 77.0
 - Angiotensin receptor blocker 39.7 39.4 26.9
 - Beta blocker 49.9 58.6 78.8 67 80.1 72.6
 - Aldosterone antagonist 44.9 53.1 59.4 40–50 32.8 53.9
 - Diuretic 68.1 81.5 87.2 83.9

SD standard deviation, BMI body mass index, NYHA New York heart association functional class, SBP systolic blood pressure, DBP diastolic blood pressure, EF ejection fraction, ACE angiotensin converting enzyme